Chicago-China Infection Control Series: Quality Improvement in Antibiotic Stewardship

All day



The University of Chicago Center in Beijing(芝加哥大学北京中心)

Department of Healthcare Associated Infections, ICDC, China CDC(中国疾控中心传染病所医院感染室)


The University of Chicago Center in Beijing and the Department of Healthcare Associated Infections, ICDC, China CDC collaborated to hold the “Chicago-China Infection Control Series: ‘Quality Improvement in Antibiotic Stewardship’” on August 4, 2011.

This workshop promoted research on Infection Control and enhanced collaborations between the University of Chicago, the China Centers for Disease Control, and other Chinese academic institutions. Through lectures and discussions, it served as a platform for the exchange of ideas between Chinese and American scholars.

This workshop provided simultaneous interpretation for lectures and discussions. Presentations were given with both English and Chinese PowerPoints.

芝加哥大学北京中心与中国疾控中心传染病所医院感染室诚邀您参加于2011年8月4日举行的“芝加哥-中国传染控制系列讲座: “抗生素应用策略质量提升”研讨会。本次研讨会的主题为中国和美国的抗生素应用策略及感染控制。




Thursday, August 4, 2011

Venue: Lecture Hall, University of Chicago Center in Beijing


09:00       Welcome


Dali YANG, Faculty Director, University of Chicago Center in Beijing

Emily LANDON MAWDSLEY, MD, University of Chicago

LU Jinxing, MD, Deputy Director, ICDC, China CDC

09:20       Antibiotic Stewardship in Chicago

Emily Landon Mawdsley, MD


10:00       Antibiotic Stewardship and Infection Control in China



10:40       Break

10:50       Discussion and Opportunities for Future Collaboration

Faculty and Participants

12:00      Adjourn and Lunch




Ben Brielmaier is a Pharm D working as an Infectious Disease Pharmacist at the University of Chicago.  He is a Board Certified Pharmacotherapy Specialist and graduated with honors from the University of Florida.  He is currently the Vice Chair of the Antimicrobial Subcommittee at the University of Chicago Medical Center and a Consulting Assistant Professor at Chicago State University College of Pharmacy.  Recent Publications include <em>Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: a retrospective, multicenter cohort study.</em>


Dr. Bin Cao graduated from Medical College of Shandong University in 1996 and received his MD degree from Peking Union Medical College in 1998. He completed resident training in internal medicine in Peking Union Medical College Hospital (PUMCH). Since 2006, he held the position of Director of Dept of Infectious Diseases &amp; Clinical Microbiology, Capital Medical University, Beijing Chaoyang Hospital and Beijing Institute of Respiratory Medicine.  Dr Cao’s research interests include community-acquired pneumonia, hospital-acquired pneumonia, pulmonary fungal infection, viral pneumonia, bacteremia and nosocomial infection control. He has more than 70 papers published in international and national journals.


Cheng Ying, MD, heads the research group of <em>Clostridium difficile</em>, with a focus on anaerobic bacterium infection in the Infection Control Unit, China CDC. She has many years of research experience on Immunology and infectious pathogens. Recently her group made several progresses in the field including whole genome sequence of <em>Clostridium difficile</em>, molecular typing and antibiotic resistance, as well as epidemiology survey.  Recent publications include Toxin A–Negative, Toxin B–Positive Clostridium difficile infection diagnosed by PCR, <a title=”Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America.” href=””>Infect Control Hosp Epidemiol.</a>

LU Jinxing

Lu Jinxing is the deputy director of the National Institute for Communicable Disease Control &amp; Prevention, ICDC, China CDC. Mr. Lu Jinxing has many years of experience in the fields of disease control and prevention, public health management and provision of service. Mr. Lu is a recognized expert in infection control. He also serves as the Technical Director of HEALTH Pharmaceutical Co., Ltd. and heads the research and production of Bifid Triple Viable Capsules. Mr. Lu has presided over a number of national research projects, including a study on the Rapid Diagnosis to the Emerging Bacterial Diseases sponsored by the Ministry of Science and Technology, one of the projects in the science research program for the 11th Five-Year Plan. Mr. Lu participated in the compilation of Architectural and Technical Code for Biosafety Laboratories and received HuaXia Construction Science and Technology Award. He graduated from Shandong University.


Emily Landon Mawdsley, MD is on the faculty of the University of Chicago as an Instructor of Medicine in the sections of Infectious Diseases &amp; Global Health as well as the section of Clinical Pharmacology.  She is the Hospital Epidemiologist and serves as the medical director for the Infection Control Program and the Antimicrobial Stewardship Program.  Her research is focused on improving care, specifically reducing the risk of healthcare-associated infection and optimizing antimicrobial utilization.  Dr. Landon Mawdsley is investigating the use of an automated system for monitoring of individual healthcare worker hand hygiene behavior. She aims to reduce risk for HAI through improved monitoring of hand hygiene compliance.


Dali L. Yang is a Professor in the Department of Political Science at the University of Chicago, founding Faculty Director of the University of Chicago Center in Beijing.  An engineering graduate from Beijing Science and Technology University, Yang received his Ph.D. in political science from Princeton University specializing in international relations and comparative politics.  He joined the University of Chicago faculty in 1992.  Professor Yang’s research interests are political institutions, political economy and political behavior with special reference to China.  Professor Yang has also been a consultant to industry, government agencies,and the World Bank.